Incidence and prognostic value of lymph node metastasis on c-Kit-positive gastrointestinal stromal tumors of the stomach

Hepato-Gastroenterology

Volumn 58, Issue 109, 2011, Pages 1224-1228

  Tokunaga, Masanori ^a   Ohyama, Shigekazu ^a   Hiki, Naoki ^a   Fukunaga, Tetsu ^a   Yamamoto, Noriko ^a   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Gastrointestinal stromal tumor; Lymph node metastasis; Stomach

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LIVER METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH TUMOR; SURGICAL MORTALITY; SURVIVAL RATE;

ADULT; AGED; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; STOMACH NEOPLASMS;

EID: 83355176169     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10018     Document Type: Article

References (24)

1. Lai IR, Lee WJ, Yu SC: Minimally invasive surgery for gastric stromal cell tumors: intermediate follow-up results. J Gastrointest Surg 2006; 10:563-6.
2. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231:51-8. (Pubitemid 30043939)
3. Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH, et al.: Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 2008; 15:52-9.
4. Bonvalot S, Eldweny H, Pechoux CL, Vanel D, Terrier P, Cavalcanti A, Robert C, Lassau N, Cesne AL, et al.: Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Ann Surg Oncol 2006; 13:1596-603. (Pubitemid 44951467)
5. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF: Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7:705-12.
6. DeMatteo RP, Maki RG, Singer S, Gonen M, Brennan MF, Antonescu CR: Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 2007; 245:347-52. (Pubitemid 46673128)
7. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, et al.: A Randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 2009; 16:910-9.
8. Gold JS, Dematteo RP: Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg 2006; 244:176-84. (Pubitemid 44305531)
9. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, et al.: Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 2007; 14: 14-24. (Pubitemid 44954266)
10. Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P, et al.: An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol 2006; 32:310-4.
11. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11:418-25. (Pubitemid 17137100)
12. Maruyama K: The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol suppl 1987; 133:63-68.
13. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T: Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989; 210:596-602. (Pubitemid 19271935)
14. Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, et al.: Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol 2004; 30:1098-103. (Pubitemid 40267815)
15. Sato T, Kanda T, Nishikura K, Hirota S, Hashimoto K, Nahagawa S, et al.: Two cases of gastrointestinal stromal tumor of the stomach with lymph node metastasis. Hepatogastroenterology 2007; 54:1057-60. (Pubitemid 47013904)
16. Canda AE, Ozsoy Y, Nalbant OA, Sagol O: Gastrointestinal stromal tumor of the stomach with lymph node metastasis. World journal of surgical oncology 2008; 6:97.
17. Valadao M, de Mello EL, Lourenco L, Vilhena B, Romano S, Castro Ldos S: What is the prognostic significance of metastatic lymph nodes in GIST? Hepatogastroenterology 2008; 55:471-4. (Pubitemid 351741484)
18. Tashiro T, Hasegawa T, Omatsu M, Sekine S, Shimoda T, Katai H: Gastrointestinal stromal tumour of the stomach showing lymph node metastases. Histopathology 2005; 47:438-9. (Pubitemid 41428498)
19. Japanese Gastric Cancer A: Japanese classification of gastric carcinoma - 2nd english edition. Gastric Cancer 1998; 1:10-24.
20. Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, et al.: Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery 2006; 139:484-92.
21. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al.: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003; 21:4342-9. (Pubitemid 46621810)
22. Wakai T, Kanda T, Hirota S, Ohashi A, Shirai Y, Hatakeyama K: Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation. Br J Cancer 2004; 90:2059-61. (Pubitemid 38869705)
23. Haller F, Detken S, Schulten HJ, Happel N, Gunawan B, Kuhlgatz J, et al.: Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. Ann Surg Oncol 2007; 14:526-32. (Pubitemid 46175297)
24. Gold JS, van der Zwan SM, Gonen M, Maki RG, Singer S, Brennan MF, et al.: Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Ann Surg Oncol 2007; 14:134-42. (Pubitemid 44954280)